Alfonso Soto‐Moreno

Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas

Raúl M. Luque, Alejandro Ibáñez‐Costa, Leonardo Vieira Neto et al. · Cancer Letters · 2015 · 89 citations

Medicine, Endocrinology, Oncology +7

Evidence of Cognitive and Neurophysiological Impairment in Patients with Untreated Naive Acromegaly

José León‐Carrión, Juan Francisco Martin‐Rodríguez, Ainara Madrazo‐Atutxa et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 87 citations · Full text

Medicine, Endocrinology, Neuroscience +17

A Cellular and Molecular Basis for the Selective Desmopressin-Induced ACTH Release in Cushing Disease Patients: Key Role of AVPR1b Receptor and Potential Therapeutic Implications

Raúl M. Luque, Alejandro Ibáñez‐Costa, Laura M. López‐Sánchez et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 81 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro

Alejandro Ibáñez‐Costa, Esther Rivero‐Cortés, Mari C. Vázquez‐Borrego et al. · Journal of Endocrinology · 2016 · 73 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features

Alejandro Ibáñez‐Costa, Manuel D. Gahete, Esther Rivero‐Cortés et al. · Scientific Reports · 2015 · 59 citations · Full text

Medicine, Endocrinology, Oncology +17